Japara Healthcare (JHC) Stock Price, News & Analysis

Company Overview

Japara Healthcare Limited, together with its subsidiaries, owns, develops, and operates residential aged care homes in Australia. It operates approximately 4,400 resident places across 51 homes located in Victoria, New South Wales, Queensland, South Australia, and Tasmania; and 180 independent living units across 5 retirement villages. The company was founded in 2005 and is based in Southbank, Australia.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: 505,569 shs
• Average Volume: N/A
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: 5.30%
• Price Target: N/A
• Consensus Rating: N/A

JHC Stock Analysis - Frequently Asked Questions

How were Japara Healthcare's earnings last quarter?

Japara Healthcare Limited (ASX:JHC) issued its earnings results on Monday, August, 27th. The company reported $0.09 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.08 by $0.01.

What other stocks do shareholders of Japara Healthcare own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Japara Healthcare investors own include Aveo Group (AOG), G8 Education (GEM), Regis Healthcare (REG), Quickstep (QHL), Orora (ORA), Medibank Private (MPL) and Ingenia Communities Group (INA).

Company Calendar

• Last Earnings: 8/27/2018
• Today: 5/04/2025

Industry, Sector and Symbol

• Stock Exchange: ASX
• Sector: Medical
• Industry: Long - Term Care Facilities
• Sub-Industry: N/A
• Current Symbol: ASX:JHC
• CIK: N/A
• Web: japarahealthcare.com.au
• Phone: +61-3-96492100
• Fax: N/A
• Employees: 6,000
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: 89.74
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: 138.13
• Current Ratio: 0.10
• Quick Ratio: 0.08

Sales & Book Value

• Annual Sales: $419.54 million
• Price / Sales: 0.00
• Cash Flow: N/A
• Price / Cash Flow: 3.17
• Book Value: A$0.79 per share
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 271,078,016
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A